MARIA VICTORIA MARTÍNEZ SÁNCHEZ

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2023 Jun 27. doi: 10.1007/s12094-023-03251-0. Online ahead of print. PubMed PMID: 37368200.

AÑO: 2023; IF: 3.4

37368200

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 Jan 4. doi: 10.1007/s12094-022-03042-z. Online ahead of print. PubMed PMID: 36598635.

AÑO: 2023; IF: 3.4

36598635

Fernandez-Sevilla LM, Valencia J, Ortiz-Sanchez P, Fraile-Ramos A, Zuluaga P, Jimenez E, Sacedon R, Martinez-Sanchez MV, Jazbec J, Debeljak M, Fedders B, Stanulla M, Schewe D, Cario G, Minguela A, Ramirez M, Varas A, Vicente A. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes. Blood. 2022 Jun 2;139(22):3303-3313. doi: 10.1182/blood.2021013506. PubMed PMID: 35313334; PubMed Central PMCID: PMC11022983.

AÑO: 2022; IF: 20.3

35313334

Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A. Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. PubMed PMID: 31411976.

AÑO: 2021; IF: 8.208

31411976

Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martínez-Sánchez MV, Campillo JA, Gomez JM, Pelaez A, García E, Herranz M, Hernández-Olivo M, Martínez-Alfaro E, Alcaraz A, Muñoz Á, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.

AÑO: 2021; IF: 7.759

33928374